Skip to content

  • Driving Innovation in Immune Profiling

    The first unbiased antigen discovery platform, IP-to-MS.
At Impact Proteomics, our patented ProMTag reversible chemistry powers our immune profiling and sample preparation technology. IP-to-MS is the first truly unbiased platform technology for antigen identification and discovery. Our Multiomics and Proteomics workflows utilize the ProMTag for fast, high-yield sample preparation.

Immunoproteomics

Separate immunoprecipitated proteins from immunoglobulins with our IP-to-MS workflow, facilitating identification of novel antigen targets in an unbiased manner.

Multiomics

Prepare high-quality, sequencing-ready DNA and RNA and either intact proteins or mass spectrometry-ready peptides for whole proteome analysis from a single starting sample with our Multiomics method.

Proteomics

Capture and cleanup whole proteomes for top-down or bottom-up analysis using ProMTag with our Proteomics method

"The IP-to-MS technology represents an extremely powerful tool in the assessment of specific humoral immune responses, with applications that range from rheumatic disease to cancer biology. This radiolabel-free approach offers the opportunity to readily detect novel autoantibody autoantigen combinations for improved characterization of immune responses, a process that was previously limited by technical factors associated with conventional immunoprecipitation methods."
-- Chief of Rheumatology, Leading Autoimmune Research Institution

You can also find us at